Spok (NASDAQ:SPOK) Announces Earnings Results

Key Points

• Spok Holdings, Inc. reported a quarterly EPS of $0.22, beating analyst estimates of $0.18 by $0.04.
• Insider transactions revealed that CEO Vincent D. Kelly and COO Michael W. Wallace both sold shares, decreasing their ownership percentages.
• Hedge fund activity showed a notable increase in holdings, with Goldman Sachs raising its stake by 33.4% in the first quarter.

Spok (NASDAQ:SPOK - Get Free Report) announced its quarterly earnings results on Wednesday. The Wireless communications provider reported $0.22 earnings per share for the quarter, beating analysts' consensus estimates of $0.18 by $0.04, Zacks reports. The business had revenue of $35.69 million during the quarter, compared to analysts' expectations of $35.00 million. Spok had a return on equity of 11.05% and a net margin of 12.12%. Spok updated its FY 2025 guidance to EPS.

Spok Stock Performance

SPOK stock traded up $0.38 during trading on Friday, hitting $18.72. The stock had a trading volume of 67,657 shares, compared to its average volume of 124,084. The stock has a market cap of $384.99 million, a price-to-earnings ratio of 22.51 and a beta of 0.58. The company's 50 day moving average price is $17.07 and its two-hundred day moving average price is $16.44. Spok has a 1-year low of $13.55 and a 1-year high of $19.31.

Spok Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 9th. Investors of record on Tuesday, August 19th will be paid a $0.3125 dividend. The ex-dividend date of this dividend is Tuesday, August 19th. This represents a $1.25 annualized dividend and a yield of 6.7%. Spok's payout ratio is presently 160.26%.

Analyst Upgrades and Downgrades

Several research firms have weighed in on SPOK. B. Riley upgraded shares of Spok to a "strong-buy" rating in a report on Thursday, May 1st. Wall Street Zen raised Spok from a "buy" rating to a "strong-buy" rating in a research note on Saturday, May 10th.

Insider Activity

In related news, CEO Vincent D. Kelly sold 30,000 shares of the firm's stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $16.40, for a total transaction of $492,000.00. Following the sale, the chief executive officer owned 157,817 shares in the company, valued at approximately $2,588,198.80. This trade represents a 15.97% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Michael W. Wallace sold 6,000 shares of the company's stock in a transaction dated Wednesday, May 7th. The shares were sold at an average price of $16.53, for a total transaction of $99,180.00. Following the transaction, the chief operating officer directly owned 61,175 shares of the company's stock, valued at approximately $1,011,222.75. This represents a 8.93% decrease in their position. The disclosure for this sale can be found here. 7.37% of the stock is owned by company insiders.

Institutional Investors Weigh In On Spok

Hedge funds have recently modified their holdings of the stock. AQR Capital Management LLC acquired a new position in Spok during the first quarter worth approximately $271,000. Jane Street Group LLC acquired a new stake in shares of Spok during the 1st quarter worth $467,000. Finally, Goldman Sachs Group Inc. boosted its holdings in Spok by 33.4% in the first quarter. Goldman Sachs Group Inc. now owns 521,571 shares of the Wireless communications provider's stock valued at $8,575,000 after acquiring an additional 130,478 shares during the last quarter. 50.81% of the stock is owned by institutional investors and hedge funds.

About Spok

Spok Holdings, Inc, through its subsidiary, Spok, Inc, provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's products and services enhance workflows for clinicians and support administrative compliance. It delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager.